retatrutide phase 2 trial results obesity VisualAbstract: reduces body weight by 17.5% in patients with Retatrutide as a Novel Treatment

January 2026: Now that the JPML has approved centralization of Wegovy and other GLP-1 NAION (vision loss) lawsuits, the Judge overseeing the litigation is likely preparing for the first stages of the MDL

For example, a nutritional goal for a PBH patient might be to consume food products that provide a maximum of 30 g carbohydrates per serving size, or cereals with a certain carbohydrate-to-fiber ratio

During the first four weeks of semaglutide therapy, monitor yourself closely for excessive drowsiness, dizziness when standing, or confusion

Effective laboratory management fosters an efficient, compliant culture

August 18, 2025: Lawsuits Against Mounjaro and Eli Lilly Will Move Forward Thousands of people alleging injuries from Mounjaro and other GLP-1 drugs are waiting to see if a federal group lawsuit against manufacturers will proceed